After a tough 2020 for med-tech deal-making, diagnostic innovation buyouts are driving a resurgence in IP-rich acquisitions
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Life sciences reporter
@IAM_Alerts ZTE and LG Electronics are two major patent owners looking to build up their licensing businesses. Both have target… https://t.co/5YmItnBtYl Read more
@IAM_Alerts Why Germany’s new government is the last hope for covid IP waiver advocates: https://t.co/eXz55wTDi0 https://t.co/rBpFjE47zg Read more
@IAM_Alerts Major US and UK SEP/FRAND reviews will have global licensing impact https://t.co/mcqzFhZ33o https://t.co/LXQxwgVilv Read more
@IAM_Alerts The UK SEP consultation launch comes just hours after the Biden administration launched its own call for comments o… https://t.co/lcK4DDiO9Y Read more